{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T17:00:10Z","timestamp":1769187610256,"version":"3.49.0"},"reference-count":35,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"China Hepatitis B Prevention and Control Research Fund Project","award":["YGFK20240098"],"award-info":[{"award-number":["YGFK20240098"]}]},{"name":"Zhangjiagang Municipal Health Youth Science and Technology Project","award":["ZJGQNKJ202317"],"award-info":[{"award-number":["ZJGQNKJ202317"]}]},{"name":"Gusu District Health Talents Program, Suzhou","award":["GSWS2023065"],"award-info":[{"award-number":["GSWS2023065"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Objective: To investigate factors influencing the anamnestic immune response 9 years after hepatitis B vaccination in elderly people (aged &gt; 60 years). Methods: We quantitatively tested 630 elderly people who participated in the free hepatitis B vaccination program for adults in Zhangjiagang City during 2015 for hepatitis B surface antibody (anti-HBs) titers. Three booster doses of hepatitis B vaccine were given to subjects with anti-HBs titers below 10 mIU\/mL, while a single booster dose was administered to those with titers between 10 and 100 mIU\/mL, in accordance with their antibody titer measurements. The post-booster anti-HBs titers were evaluated at 2\u20133 months. A logistic regression model was used to identify factors influencing the anamnestic immune response, and a receiver operating characteristic curve analysis was conducted. Results: Among the 90 participants who received three doses and the 101 participants who received one dose, baseline characteristics did not differ significantly between the two cohorts. Both groups exhibited robust anamnestic immune responses. Significant differences were observed before and after booster vaccination within each group (Z = \u22128.24, p &lt; 0.001; Z = \u22128.73, p &lt; 0.001). Multivariate logistic regression indicated that individuals with higher pre-booster anti-HBs titers were less likely to show weak anamnestic responses compared to those with lower pre-booster titers (OR = 0.30, 95% CI: 0.16\u20130.58). Furthermore, a high anamnestic immune response (&gt;1000 mIU\/mL) was significantly more frequent among subjects with pre-booster titers \u2265 4.58 mIU\/mL. Conclusions: Booster immunization administered nine years after hepatitis B vaccination induces robust anamnestic immunity, with its magnitude significantly correlated with pre-booster anti-HBs titers. Particular attention should be given to individuals with extremely low pre-booster anti-HBs levels.<\/jats:p>","DOI":"10.3390\/vaccines14020111","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T14:58:40Z","timestamp":1769180320000},"page":"111","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors Associated with the Anamnestic Immune Response Following Hepatitis B Booster Vaccination in the Elderly"],"prefix":"10.3390","volume":"14","author":[{"given":"Chen","family":"Wang","sequence":"first","affiliation":[{"name":"Zhangjiagang Center for Disease Control and Prevention, Zhangjiagang 215600, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zou","sequence":"additional","affiliation":[{"name":"Zhangjiagang Center for Disease Control and Prevention, Zhangjiagang 215600, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Wang","sequence":"additional","affiliation":[{"name":"Zhangjiagang Center for Disease Control and Prevention, Zhangjiagang 215600, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[{"name":"Suzhou Center for Disease Control and Prevention, Suzhou 215100, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Dong, Z., Li, J.R., Zhao, Z.X., Xu, L., Yu, W., Kang, W.Y., and Li, Q.F. (2021). Molecular epidemiology of hepatitis B virus genotypes and subgenotypes in ethnic minority populations, Yunnan province, China. Epidemiol. Infect., 150.","DOI":"10.1017\/S0950268821002326"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-13-9151-4_1","article-title":"Hepatitis B Virus Infection: Overview","volume":"1179","author":"Li","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/lt.21376","article-title":"Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index","volume":"14","author":"Dan","year":"2008","journal-title":"Liver Transpl."},{"key":"ref_4","unstructured":"World Health Organization (2025, December 09). Key Facts of Hepatitis B. Available online: http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Wang, H., Men, P., Xiao, Y., Gao, P., Lv, M., Yuan, Q., Chen, W., Bai, S., and Wu, J. (2019). Hepatitis B infection in the general population of China: A systematic review and meta-analysis. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-4428-y"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Liu, W., Zhuang, T., Xia, R., Zou, Z., Zhang, L., Shen, M., and Zhuang, G. (2022). Modelling the prevalence of hepatitis B towards eliminating it as a major public health threat in China. BMC Public Health, 22.","DOI":"10.1186\/s12889-022-13594-y"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2471\/BLT.18.219469","article-title":"Countdown to 2030: Eliminating hepatitis B disease, China","volume":"97","author":"Liu","year":"2019","journal-title":"Bull. World Health Organ."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.1093\/infdis\/jiaa668","article-title":"Hepatitis B Vaccines","volume":"224","author":"Pattyn","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Makan, N., Song, E., Kinge, C.W., and Kramvis, A. (2023). Hepatitis B virus immunity prior to and after administration of a \u2018booster\u2019 dose of vaccine among health-care students at a South African university. Vaccine X, 14.","DOI":"10.1016\/j.jvacx.2023.100284"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00103-013-1845-8","article-title":"Background paper to the revised recommendation for hepatitis B vaccination of persons at particular risk and for hepatitis B postexposure prophylaxis in Germany","volume":"56","author":"Harder","year":"2013","journal-title":"Bundesgesundheitsbl. Gesundheitsforsch. Gesundheitsschutz"},{"key":"ref_11","first-page":"693","article-title":"Immunogenicity and influencing factors of hepatitis B vaccine in adults over 40 years old","volume":"24","author":"Zhao","year":"2023","journal-title":"Chin. Prev. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Yang, S., Tian, G., Cui, Y., Ding, C., Deng, M., Yu, C., Xu, K., Ren, J., Yao, J., and Li, Y. (2016). Factors influencing immunologic response to hepatitis B vaccine in adults. Sci. Rep., 6.","DOI":"10.1038\/srep27251"},{"key":"ref_13","first-page":"1278","article-title":"Research Progress on the Relationship among Immunosenescence, Tumors, and Infections","volume":"99","author":"Zhao","year":"2019","journal-title":"Natl. Med. J. China"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Hanafi, N.F., Omar, N.N., Ismail, G.A., El-Kholy, A.A., ElShafei, A., and Essa, S.A. (2025). Anti-HBs persistence and anamnestic response among medical interns vaccinated in infancy. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-00055-w"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Zhang, X., Zou, H., Chen, Y., Zhang, H., Tian, R., Meng, J., Zhu, Y., Guo, H., Dai, E., and Zhu, B. (2021). The effects of increased dose of hepatitis B vaccine on mother-to-child transmission and immune response for infants born to mothers with chronic hepatitis B infection: A prospective, multicenter, large-sample cohort study. BMC Med., 19.","DOI":"10.1186\/s12916-021-02025-1"},{"key":"ref_16","first-page":"497","article-title":"[Persistence of immune memory and its related factors at 12 years after hepatitis B vaccination among adults]","volume":"53","author":"Zhang","year":"2019","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1099\/jmm.0.001086","article-title":"Evaluation of antibody persistence after a four-dose primary hepatitis B vaccination and anamnestic immune response in children under 6 years","volume":"68","author":"Tfifha","year":"2019","journal-title":"J. Med. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.vaccine.2018.03.028","article-title":"Long-term immunity to hepatitis B following vaccination in infancy: Real-world data analysis","volume":"36","author":"Klinger","year":"2018","journal-title":"Vaccine"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Cocchio, S., Baldo, V., Volpin, A., Fonzo, M., Floreani, A., Furlan, P., Mason, P., Trevisan, A., and Scapellato, M.L. (2021). Persistence of Anti-Hbs after up to 30 Years in Health Care Workers Vaccinated against Hepatitis B Virus. Vaccines, 9.","DOI":"10.3390\/vaccines9040323"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Tahir, A., Shinkafi, S.H., Alshrari, A.S., Yunusa, A., Umar, M.T., Hudu, S.A., and Jimoh, A.O. (2024). A Comprehensive Review of Hepatitis B Vaccine Nonresponse and Associated Risk Factors. Vaccines, 12.","DOI":"10.3390\/vaccines12070710"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Chang Villacreses, M.M., Karnchanasorn, R., Ou, H.Y., Samoa, R., Chuang, L.M., and Chiu, K.C. (2022). The impact of glucose tolerance state on seropositivity rate after hepatitis B vaccination. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-07163-x"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhang, Z. (2016). Model building strategy for logistic regression: Purposeful selection. Ann. Transl. Med., 4.","DOI":"10.21037\/atm.2016.02.15"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Xu, X., Xu, Y., and Shi, R. (2024). Association between obesity, physical activity, and cognitive decline in Chinese middle and old-aged adults: A mediation analysis. BMC Geriatr., 24.","DOI":"10.1186\/s12877-024-04664-4"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00535-017-1316-3","article-title":"Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes","volume":"52","author":"Kato","year":"2017","journal-title":"J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Yan, B., Lu, J., Jia, L., Feng, Y., Wang, J., Meng, X., Liang, X., Wang, F., Wan, Y., and Xu, A. (2023). Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control. Hum. Vaccin. Immunother., 19.","DOI":"10.1080\/21645515.2023.2168432"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/hep.32474","article-title":"Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose","volume":"76","author":"Bruce","year":"2022","journal-title":"Hepatology"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Qiu, Q., Wang, H., Liu, X., Peng, X., and Zhang, W. (2024). Comparative Immunogenicity of a High-Dose Hepatitis B Virus (HBV) Vaccine with Rapid Immunization vs. Standard Schedule in HBV Vaccine-Na\u00efve Adults Aged 25-55 in China. Vaccines, 12.","DOI":"10.3390\/vaccines12080923"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1016\/j.vaccine.2005.03.017","article-title":"Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants","volume":"23","author":"Fitzsimons","year":"2005","journal-title":"Vaccine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1080\/21645515.2018.1477911","article-title":"Persistence of immune memory among adults with normal and high antibody response to primary hepatitis B vaccination: Results from a five-year follow-up study in China","volume":"14","author":"Wu","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_30","first-page":"153","article-title":"Immune persistence and anamnestic responses 18\u201320 years after vaccination with Chinese hamster ovary cell derived hepatitis B vaccine in Zhengding county of Hebei province","volume":"29","author":"Wang","year":"2023","journal-title":"Chin. J. Vaccines Immun."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Tobia, L., Zag\u00e0, R.F., Mattei, A., Cipollone, C., Cipriani, A., Sedile, A.I., Fabiani, L., and Bianchi, S. (2024). Efficacy of HBV booster dose administration in Italian medical students in relation to health determinants. Hum. Vaccin. Immunother., 20.","DOI":"10.1080\/21645515.2024.2439049"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Papadopoli, R., De Sarro, C., Torti, C., Pileggi, C., and Pavia, M. (2020). Is There Any Opportunity to Provide an HBV Vaccine Booster Dose Before Anti-Hbs Titer Vanishes?. Vaccines, 8.","DOI":"10.3390\/vaccines8020227"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/jvh.13125","article-title":"Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults","volume":"26","author":"Dionne","year":"2019","journal-title":"J. Viral Hepat."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Wang, W.C., Lin, Y.S., Chang, Y.F., Yeh, C.C., Su, C.T., Wu, J.S., and Su, F.H. (2021). Association of HLA-DPA1, HLA-DPB1, and HLA-DQB1 Alleles with the Long-Term and Booster Immune Responses of Young Adults Vaccinated Against the Hepatitis B Virus as Neonates. Front Immunol., 12.","DOI":"10.3389\/fimmu.2021.710414"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1080\/21645515.2016.1250990","article-title":"Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China","volume":"13","author":"Wang","year":"2017","journal-title":"Hum. Vaccin. Immunother."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/2\/111\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T15:13:20Z","timestamp":1769181200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/2\/111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["vaccines14020111"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14020111","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]}}}